Australia's most trusted
source of pharma news
Wednesday, 26 November 2025
Posted 26 November 2025 AM
AstraZeneca has been named the 'Most Valued Pharma Company' in a survey of Australian clinicians, ticked as first choice by 22 per cent of respondents.
CSL took second place with 17 per cent of doctors naming the company as their number one choice, followed by Pfizer which was first choice for eight percent of respondents.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.